Fuji Pharma

4554.TPharmaceutical

Key numbers · FY ended 2025-09

Revenue¥51.7bn+12.0% YoY Operating income¥5.0bn+28.6% YoY Net income (owners)¥3.0bn-51.2% YoY Total assets¥93.4bn+3.8% YoY EPS (basic)¥122.94-51.4% YoY

Full financial history and reports →

Stock price4554 · View chart ↗

Open the price chart on TradingView.

Latest filings

Fri, Jul 31 · JST1 filing

16:095% STAKEFuji Pharma · FJP Co., Ltd. + 2 joint holders · 31.67% → 29.99%−1.68pp

Tue, Jun 23 · JST1 filing

16:315% STAKEFuji Pharma · FJP Co., Ltd. + 2 joint holders · 32.74% → 31.67%−1.07pp

Fri, May 29 · JST1 filing

15:355% STAKEFuji Pharma · FJP Co., Ltd. + 2 joint holders · 33.77% → 32.74%−1.03pp

Thu, Feb 12 · JST1 filing

09:345% STAKEFuji Pharma · Nomura Securities Co., Ltd. + 1 joint holder · 10.79% → 9.76%−1.03pp

Fri, Aug 8 · JST1 filing

14:135% STAKEFuji Pharma · Nomura Securities Co., Ltd. + 2 joint holders · 18.45% → 10.79%−7.66pp

All filings →

Major holders (5%+) · 3

Holder	Stake	Change	Filed
FJP Co., Ltd.	16.23%	0.00pp	2026-07-31
Hirofumi Imai	9.99%	-1.69pp	2026-07-31
Nomura Securities Co., Ltd.	9.76%	-1.03pp	2026-02-12

Each holder's own ratio from its most recent large-shareholding report.